Brainstorm Cell Therapeutics

325 Avenue of the Americas, NY, New York 10019, USA

Website

201-488-0460

Overview

BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as

  • Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease and Motor Neuron Disease)
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Huntington’s Disease

Our platform technology, NurOwn®, uses proprietary culture conditions to induce mesenchymal stem cells (MSCs) to secrete high levels of neurotrophic factors (NTFs) known to promote the survival of neurons. Our research efforts have shown that these MSC-NTF cells might be an effective tool for battling neurodegenerative diseases.

Map

Get Directions View Large Map

https://www.linkedin.com/company/brainstorm-cell-therapeutics/

Posted in Corporations

Reviews are disabled, but trackbacks and pingbacks are open.

Related Listings

Sangamo Therapeutics

(510) 970-6000

501 Canal Blvd, Richmond, CA 94804, USA

Sangamo Therapeutics (Nasdaq:SGMO) Accelerating toward the future of new genomic therapies – Since the first mapping of the human genome was completed 18 years ago, the progress… Read more…

Caladrius Biosciences

908 842 0100

110 Allen Road, Basking Ridge, NJ 07920, USA

Caladrius (Nasdaq:CLBS) is a clinical-stage biopharmaceutical company committed to the development of innovative products in cardiovascular and autoimmune disease that have the potential to restore the health… Read more…